CPHI Europe 2025 Opens with a Focus on Sustainability, AI and Supply Agility
CPHI Europe spotlights sustainability, automation, resilience and global pharma collaboration
CPHI Europe spotlights sustainability, automation, resilience and global pharma collaboration
Europe shifts toward defence sovereignty amid realignment and investment growth
Digital therapeutics and neurotech ecosystems are evolving into regulated, scalable infrastructure for mental health.
The global Defence AR/VR & Simulation market is projected to grow at a CAGR of 5.8% by 2035
From lab to doorstep, digital logistics are becoming the backbone of decentralised global healthcare delivery.
The global Battery Recycling & Second-Life Battery market is projected to grow at a CAGR of 20.1% by 2035
The global Mobility-as-a-Service (MaaS) market is projected to grow at a CAGR of 30.5% by 2035
The global Battery Metals & Critical Minerals market is projected to grow at a CAGR of 12.3% by 2035
The global Solid-State Car Battery market is projected to grow at a CAGR of 40.7% by 2035
The move from monotherapy to combination therapy marks a pivotal change in how medicine addresses complex diseases.
The global Smart & Sustainable Materials market is projected to grow at a CAGR of 12.7% by 2035
The global Hypersonic Weapons market is projected to grow at a CAGR of 11.8% by 2035
From lab to cloud, digital diagnostics are becoming infrastructure-grade, interoperable pillars of modern healthcare.
The global Digital Twins in Automotive market is projected to grow at a CAGR of 33.2% by 2035
The global Clinical Trial Supply and Logistics Market for Pharma is projected to grow at a CAGR of 10.1% by 2035
The global Military Radar System market is projected to grow at a CAGR of 4.6% by 2035
Immunohistochemistry links molecular biomarkers with digital pathology, driving precision oncology and personalised treatment decisions.
The global Directed Energy Weapons (DEW) market is projected to grow at a CAGR of 19.8% by 2035
The global Anti-Drone market is projected to grow at a CAGR of 28.9% by 2035
Rising biomarker trials, FDA approvals, and AI integration define the next growth phase in oncology.